TOKYO--(BUSINESS WIRE)--Modulus Discovery, Inc., a preclinical-stage technology-driven drug discovery firm, announces the successful closing of its series B funding round in the amount of 2.71 B JPY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback